Indivior Pharmaceuticals Inc (NASDAQ:INDV) Q4 2025 Earnings Call Transcript February 26, 2026
Indivior Pharmaceuticals Inc beats earnings expectations. Reported EPS is $0.82, expectations were $0.65.
Operator: Thank you for standing by. Welcome to Indivior Pharmaceuticals Inc’s fourth quarter and full year 2025 results conference call and webcast. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. To ask a...
